아네불로 파마슈티컬스(ANEB) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

🏛️

거래 정지 중인 종목 2026-06-04 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.

ANEB

Anebulo Pharmaceuticals Inc

7월 27일 4:00 PM ET (한국 7/28 05:00)

$0.36

+0.00 +0.00%

아네불로 파마슈티컬스(ANEB) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$15M

스몰캡

P/E

배당수익률

없음

52주 위치

저점 +3% · 고점 -89%

애널리스트

보유

Fundamental health

vs. 전체 시장· based on 2 axes

수익성

산출 불가 (적자)

성장

Top 77%

밸류에이션

데이터 부족

재무 안정

Top 45%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-0.19	Insider Own ⓘ	40.54%	Shs Outstand ⓘ	41.1M	Perf Week ⓘ	-16.49%
Market Cap ⓘ	0.01B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	-	Shs Float ⓘ	24.3M	Perf Month ⓘ	-62.11%
Enterprise Value ⓘ	0.01B	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	54.45%	Short Float ⓘ	0.6%	Perf Quarter ⓘ	-84.87%
Income ⓘ	-0.01B	P/S ⓘ	-	EPS this Y ⓘ	-	Inst Trans ⓘ	-0.4%	Short Ratio ⓘ	1.47	Perf Half Y ⓘ	-85.37%
Sales ⓘ	0.00B	P/B ⓘ	1.86	EPS next 5Y ⓘ	-	ROA ⓘ	-63.16%	Short Interest ⓘ	0.15M	Perf YTD ⓘ	-64.36%
Book/sh ⓘ	0.19	P/C ⓘ	1.62	EPS past 3/5Y ⓘ	4.97% -102.33%	ROE ⓘ	-69.69%	52W High ⓘ	-89.47% ($3.42)	Perf Year ⓘ	-70%
Cash/sh ⓘ	0.22	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-	ROIC ⓘ	-100.53%	52W Low ⓘ	2.8% ($0.35)	Perf 3Y ⓘ	-87.59%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	33.15%	Gross Margin ⓘ	-	Volatility(W/M) ⓘ	20.46% 13.97%	Perf 5Y ⓘ	-
Dividend TTM ⓘ	-	EV/Sales ⓘ	-	Sales Y/Y TTM ⓘ	-	Oper. Margin ⓘ	-	ATR (14) ⓘ	0.08	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	6.24	EPS Q/Q ⓘ	45.77%	Profit Margin ⓘ	-	RSI (14) ⓘ	17.88	Recom ⓘ	3
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	6.24	Sales Q/Q ⓘ	-	SMA20 ⓘ	-38.08% ($0.58)	Beta ⓘ	-0.7	Target Price ⓘ	$3
Payout ⓘ	-	Debt/Eq ⓘ	0	Earnings ⓘ	2026/2/12	SMA50 ⓘ	-63.51% ($0.99)	Rel Volume ⓘ	0	Prev Close ⓘ	$0.36
Employees ⓘ	3	LT Debt/Eq ⓘ	0	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-80.48% ($1.84)	Avg Volume(3M) ⓘ	0.10M	Price ⓘ	$0.36
IPO ⓘ	2021/5/7	Option/Short ⓘ	No/Yes			Trades ⓘ	0	Volume ⓘ	-	Change ⓘ	-

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 Anebulo Pharmaceuticals Inc (ANEB) Investment Analysis

What kind of company is Anebulo Pharmaceuticals Inc?

아네불로 파마슈티컬스(ANEB)

Healthcare · Biotechnology

Small-Cap — Low Volume, High Volatility

🔬 Anebulo Pharmaceuticals (ANEB) is a biotechnology company specializing in the development of novel antidotes and antagonists designed to rapidly alleviate symptoms of acute cannabis intoxication and central nervous system-related metabolic disorders.

Learn more about Anebulo Pharmaceuticals Inc →

Market Cap

$0.0B

Approx. KRW 0.0 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank5361

Employees3people

IPO2021/05/07

Current Price$0.36 ≈ 493원

NASD · USA

Key Events

예정된 이벤트가 없습니다

ANEB의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

실적 발표는 보통 분기마다 있습니다
배당주는 연 1~4회 배당락일이 있습니다

전체 경제/실적 캘린더 보기 →

Is it profitable?

Financially sound but profitability is low

Losses or thin margins — early-stage growth or weakening competitiveness

Profitability — How efficiently it makes money

ROE

Annual return earned on shareholders' equity (15%+ is strong)

-69.7%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROA

Annual earnings relative to total company assets

-63.2%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROIC

Return generated per dollar invested in the business

-100.5%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.00

✓ Very low debt

My positionTop 5%

Low range Average High range

전체 시장 Median 0.40

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

6.24

✓ 우수

My positionTop 25%

Low range Average High range

전체 시장 Median 1.70

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

6.24

✓ 우수

My positionTop 25%

Low range Average High range

전체 시장 Median 1.47

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$3.00

현재가 대비 +733.3%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth

Mid-range within the industry

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

+5.0%

평균

My positionMid-range

Low range Average High range

전체 시장 Median 7.6% · Bottom 47%

Past 5-Year EPS

Actual average annual EPS growth over the past 5 years

-102.3%

매우 부진

My positionBottom 5%

Low range Average High range

전체 시장 Median 9.7% · Bottom tier

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Underperformed the market by 86%p over the past year

ANEB -70.0% · S&P 500 +16.0%

Excess return vs. market (price-based, ex-dividends)

1-year basis

vs S&P 500

-86.0%p

Significantly behind the market

vs Health Care (XLV)

-89.7%p

Significantly behind the sector average

Current position within 52-week range

Low (-2.8%p) High (-89.5%p)

Current price is 2.8% above the 52-week low and 89.5% below the 52-week high

Recent risk (last 31 trading days)

Max drawdown

-66.7%

Annualized volatility

172.9%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 88-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-05-15

Downtrend zone

Current price $0.46 below the midline ($0.47). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-05-15

Neutral zone — weak trend

MACD -0.034 · Signal -0.045 · Hist 0.012. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-05-15

Bearish zone

RSI 42.6 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 28.3.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average

In line with peers on Vs. Assets

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

🏢 Vs. Assets Mid-range

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

1.86x

✓ Fair

My positionMid-range

Low range Average High range

전체 시장 median 1.76x · Around the industry average

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

Analyst target price (reference)

$3.00 vs. current price +733.3%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: 전체 시장

Who owns it?

Ownership is broadly stable

Institutional modest net selling -0.4% · Short interest light 0.6%

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

0.0%

Insiders little change

🏦 Institutions (funds & investors)

-0.4%

Institutions net selling

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 54.5%

Adequate institutional weight

전체 시장 Median 48.6%

🧑‍💼 Insiders 40.5%

Founder/management large holders (strong skin-in-the-game)

전체 시장 Median 12.2%

👤 Retail investors (estimated) 5.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

0.6%

Low — limited short-side pressure

전체 시장 Median 4.0%

Past 31 days Little change

Short interest days to cover

1.5 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 41.1M주

Float (tradable shares) 24.3M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 31 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
ANEB This Stock	$14.7M	-	1.9 ▲	-69.69% ▼	-	+0.0%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 아네불로 파마슈티컬스(ANEB)?

아네불로 파마슈티컬스(ANEB) belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of ANEB?

The market cap of ANEB is approximately $15M, ranking 5,361 within its sector.

What is the 52-week high and low for ANEB?

ANEB has recorded a 52-week high of $3.42 and a low of $0.35.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.